comprehensive -WSS

comprehensive

author：explore 2025-09-30 00:47:29 - browse：52861

A doctor climbs up a red ladder to a vine shaped like a DNA — biotech coverage from STAT — Adobe

Every morning, Victoria Rasberry gets up before 6 a.m., walks to the bedroom down the hall, and helps her 8-year-old daughter Addi slide into a set of contraptions that squeeze and suck out the thick mucus constantly threatening to choke her airways closed. She feeds Addi breakfast through a stomach tube and makes sure she has the right mix of the 28 different medications required to keep her free of pain, infections, and seizures. At some point, Rasberry’s five other children will wake up and start to get ready for school, including her youngest, Oliver. At 3-and-a-half years old, he’s a typical toddler — always running and giggling and getting into things. You would never know that he and Addi were born with the same mutation lurking in their DNA, a genetic glitch that causes a fatal neurodegenerative disease called metachromatic leukodystrophy, or MLD.

“When Addi was this age she had lost the ability to speak and was already using a ventilator to sleep at night,” Rasberry said. “It’s amazing to see how well Ollie is doing in comparison. And it’s all because of the gene therapy.”

Three years ago, when Ollie was just 6 months old, he and Victoria traveled from their home in Texas to Milan, to receive a gene therapy treatment that adds a healthy version of the defective gene into patients’ own stem cells. At the time, traveling abroad for the therapy, which is manufactured by Orchard Therapeutics and was approved in Europe in 2021, was the only option for families stricken by MLD. But soon it will be available in the U.S., too.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： STAT letters to the editor on burnt

entertainment

WSS

Radiology is caught between AI's potential and concern for patients

FDA needs staff influx to meet gene therapy needs, Marks says

The unintended consequences of overturning Roe v. Wade

Transgender sports debate: Physicians say bans are health issue

Eli Lilly CEO gives to Mike Pence presidential super PAC

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Wikipedia

comprehensive

focus

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What happened to the House vote on health price transparency?

United colonoscopy coverage change 'may cost lives,' doctors say

Assistant physicians can help address the primary care shortage

Jerome Adams on the need for new antivirals for Covid

Americans' trust in science, scientist continues decline: Report

Jerome Adams on the need for new antivirals for Covid

Why the quest to eradicate polio has stumbled

Dobbs anniversary: the lost opportunity of abortion as health care

Information blocking fines are now fair game in health care

knowledge

FDA needs staff influx to meet gene therapy needs, Marks says

Midwives could help bridge maternal health disparities in the U.S.

Medicare to pay more for cardiac rehab in hospital outpatient clinics

David Liu startup to focus on CRISPR delivery

Teach medical students about patients with intellectual disabilities

Information blocking fines are now fair game in health care

focus

explore

entertainment

explore